PTCH2 and breast cancer: Our results showed that the LC3II/LC3I ratio is reduced in siPTCH2 compared with siGLO BC cells (Figure 5B) and more interestingly, FACS analysis displayed that PTCH2 knockdown decreased the expression of vimentin and α5 integrin subunit in CPS-treated cells.